Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of Ipilimumab in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer
jRCT2080221195Phase 1
- Sponsor
- Bristol Myers Squibb
- Start
- Aug 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1 trial of ipilimumab in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Bristol Myers Squibb.
02
Drugs
ipilimumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on jRCT2080221195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221195.